US Stock Market Closed

Dashboard

Arrowhead Pharmaceuticals, Inc. (ARWR)

Current

- (-)

After Hours

Rating & Fair Value

Fair Value Premium lock
Institutional Holdings

H

Financial Strength

H

Sustainable Growth

S

Industry Comparison

H

Management & Equity

B

Analyst Opinion

B

Leverage & Liquidity

B

Fundamental Variables

H

Rating Performance

FV Performance

About

Arrowhead Pharmaceuticals, Inc. operates as a biopharmaceutical company. It develops medicines that treat intractable diseases by silencing the genes that cause them. The company was founded by R. Bruce Stewart in 1989 and is headquartered in Pasadena, CA.

CEO

Christopher Richard Anzalone

Employees

134

Industry

Digestive System Biopharmaceuticals

Sector

Healthcare

Headquarters

Pasadena

Exchange

NASDAQ

Summary Stats

Market Cap

3.12B

Revenue

250M

Net Income

-154M

EPS

-$1.46

Price-to-Earnings

-20.21

Price-to-Book

6.59

Debt-to-Equity

0.59

News

Analyst Ratings

Price targets projected by 11 analysts

High

$98.00

Average

$77.73

Low

$34.00

Ratings calculated by 11 analysts

Buy

9

Hold

2

Sell

0

Last Dividend

Amount

-

Dividend Date

-

Frequency

-

Dividend Yield

Earnings

Most Recent Earnings

Last Earnings for Q3 2022

Last Earnings

Missed by -$0.17

Actual

-$0.68 -33.3%

Consensus

-0.51

Report Date

Year Ago

-0.29

Year Ago Change %

Down 134%

Actual vs Estimates

XX

xxx

Upcoming Estimates Unavailable

Expected EPS
-

-

Actual EPS
-

--

Competitors

star Favorites